Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard P Gale

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Expert Opinion on Investigational Drugs|April 25, 2009
Recent developments in the treatment of uveitis: an updateFiona Lyon, Richard P Gale, Susan Lightman
Expert Opinion on Pharmacotherapy|July 6, 2013
Overview and recent developments in the medical management of paediatric uveitisBertrand Pilly, Greg Heath, Patrizia Tschuor, et al.
Eye (London, England)|December 16, 2022
Optical coherence tomography imaging biomarkers associated with neovascular age-related macular degeneration: a systematic reviewRachel L W Hanson, Archana Airody, Sobha Sivaprasad, et al.
Ophthalmology and Therapy|August 10, 2020
Demographic and Clinical Factors that Influence the Visual Response to Anti-Vascular Endothelial Growth Factor Therapy in Patients with Neovascular Age-Related Macular Degeneration: A Systematic ReviewClaire R Gill, Catherine E Hewitt, Tracy Lightfoot, et al.
Trials|December 30, 2025
Early Detection Of neovascular age-Related mAcular Degeneration in the cOmmunity assessing persistence, adherence and acceptability: study protocol for the DORADO randomized controlled trialRachel L W Hanson, Archana Airody, Ahmed Saad, et al.
Current Opinion in Neurology|January 22, 2009
Electrodiagnostic assessment in optic nerve diseaseGraham E Holder, Richard P Gale, James F Acheson, et al.
Investigative Ophthalmology & Visual Science|May 27, 2022
Cortical Atrophy Predicts Visual Performance in Long-Term Central Retinal Disease; GCL, pRNFL and Cortical Thickness Are Key BiomarkersRachel L W Hanson, Heidi A Baseler, Archana Airody, et al.
Ophthalmology and Therapy|March 12, 2022
An Introduction to Biosimilars for the Treatment of Retinal Diseases: A Narrative ReviewSeenu M Hariprasad, Richard P Gale, Christina Y Weng, et al.
Plos One|June 4, 2015
Treatment Satisfaction and Well-Being in Patients with Myopic Choroidal Neovascularization Treated with Ranibizumab in the REPAIR StudyWinfried M Amoaku, Richard P Gale, Andrew J Lotery, et al.
Acta Ophthalmologica|April 20, 2026
The long-term impact of neovascular age-related macular degeneration undergoing routine treatment in first and second eyes on vision-related quality-of-life: FASBAT Report 3Archana Airody, Rachel L W Hanson, Isabel Bunola-Hadfield, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Expert Opinion on Investigational Drugs|April 25, 2009
Recent developments in the treatment of uveitis: an updateFiona Lyon, Richard P Gale, Susan Lightman
Expert Opinion on Pharmacotherapy|July 6, 2013
Overview and recent developments in the medical management of paediatric uveitisBertrand Pilly, Greg Heath, Patrizia Tschuor, et al.
Eye (London, England)|December 16, 2022
Optical coherence tomography imaging biomarkers associated with neovascular age-related macular degeneration: a systematic reviewRachel L W Hanson, Archana Airody, Sobha Sivaprasad, et al.
Ophthalmology and Therapy|August 10, 2020
Demographic and Clinical Factors that Influence the Visual Response to Anti-Vascular Endothelial Growth Factor Therapy in Patients with Neovascular Age-Related Macular Degeneration: A Systematic ReviewClaire R Gill, Catherine E Hewitt, Tracy Lightfoot, et al.
Trials|December 30, 2025
Early Detection Of neovascular age-Related mAcular Degeneration in the cOmmunity assessing persistence, adherence and acceptability: study protocol for the DORADO randomized controlled trialRachel L W Hanson, Archana Airody, Ahmed Saad, et al.
Current Opinion in Neurology|January 22, 2009
Electrodiagnostic assessment in optic nerve diseaseGraham E Holder, Richard P Gale, James F Acheson, et al.
Investigative Ophthalmology & Visual Science|May 27, 2022
Cortical Atrophy Predicts Visual Performance in Long-Term Central Retinal Disease; GCL, pRNFL and Cortical Thickness Are Key BiomarkersRachel L W Hanson, Heidi A Baseler, Archana Airody, et al.
Ophthalmology and Therapy|March 12, 2022
An Introduction to Biosimilars for the Treatment of Retinal Diseases: A Narrative ReviewSeenu M Hariprasad, Richard P Gale, Christina Y Weng, et al.
Plos One|June 4, 2015
Treatment Satisfaction and Well-Being in Patients with Myopic Choroidal Neovascularization Treated with Ranibizumab in the REPAIR StudyWinfried M Amoaku, Richard P Gale, Andrew J Lotery, et al.
Acta Ophthalmologica|April 20, 2026
The long-term impact of neovascular age-related macular degeneration undergoing routine treatment in first and second eyes on vision-related quality-of-life: FASBAT Report 3Archana Airody, Rachel L W Hanson, Isabel Bunola-Hadfield, et al.
Pageof 4